Erlonat 150 Tablet

Get a Price/Quote

Erlonat 150 Tablet Specification

Indication
Non-small cell lung cancer, Pancreatic cancer

Dosage Form
Tablet

Salt Composition
Erlotinib Hydrochloride

Feature
Oral anti-cancer agent

Ingredients
Erlotinib Hydrochloride 150mg

Application
Oncology (anti-cancer therapy)

Physical Color/Texture
White to off-white tablets

Fermentation Smell
Odorless

Shelf Life
24 months

Erlonat 150 Tablet Trade Information

Minimum Order Quantity
100 box,

Payment Terms
Letter of Credit (L/C), Paypal, Western Union, Cash in Advance (CID), Cash Advance (CA)

Delivery Time
30 Days

Sample Policy
Within a certain price range free samples are available

Main Export Market(s)
Australia, North America, South America, Eastern Europe, Middle East, Western Europe, Central America, Asia, Africa

Certifications
ISO, GMP, WHO

About Erlonat 150 Tablet

Erlonat 150 Tablet

Product Description

Catering to wide requirements of clients since years, we have been successfully engaged in exporting an excellent stock of Erlonat 150 (Erlotinib Tablet). The medicine is offered in excellent packing to clients at feasible prices. The medication is indicated for maintenance treatment, 1st-line treatment and 2nd- or 3rd-line treatment for advanced-stage non-small cell lung cancer (NSCLC). In addition, Erlonat 150 (Erlotinib Tablet) is also clinically approved for advanced-stage pancreatic cancer.

Key points:

It belongs to a specific class of medicines called kinase inhibitors
It blocks action of an abnormal protein that signals cancer cells to multiply

Specifications:

Brand : Erlonat
Contain : Erlotinib Tab
strength : 25mg /150mg
Packing : 30 Tab Bollte

Product details

Usage	Clinical, Hospital
Packaging Size	30 Tab Bottel
Gender	Unisex
Brand	Erlonat

Targeted Cancer Therapy Simplified

Erlonat 150 Tablet delivers focused treatment for non-small cell lung cancer and pancreatic cancer using advanced targeted therapy. As a tyrosine kinase inhibitor, its active ingredient, Erlotinib Hydrochloride, works specifically at the cellular level, reducing harm to healthy cells. With oral administration, patients benefit from convenient dosing at home, under medical supervision.

Quality and Assurance from Natco Pharma

Manufactured by Natco Pharma Ltd., Erlonat 150 Tablets are produced with stringent quality standards. The tablets are odorless and come in a stable, easy-to-store pack, ensuring efficacy and safety throughout their shelf life. Each batch is carefully tested to guarantee the right strength and purity for effective oncology treatment.

FAQs of Erlonat 150 Tablet:

Q: How should Erlonat 150 Tablet be taken for optimal effectiveness?

A: Erlonat 150 Tablet should be taken orally, exactly as prescribed by your oncologist. Usually, it is taken on an empty stomach, at least 1 hour before or 2 hours after meals, to ensure maximum absorption and effectiveness.

Q: What is the primary benefit of using Erlonat 150 Tablet in cancer therapy?

A: Erlonat 150 works by inhibiting tyrosine kinases, which are enzymes involved in the growth and spread of cancer cells. This targeted approach slows cancer progression and can improve the efficacy of cancer treatment in patients with non-small cell lung cancer or pancreatic cancer.

Q: When is Erlonat 150 Tablet indicated for use?

A: Erlonat 150 is indicated for the treatment of patients diagnosed with non-small cell lung cancer and pancreatic cancer, as recommended by a qualified healthcare provider, based on specific clinical guidelines.

Q: Where should Erlonat 150 Tablets be stored to ensure longevity?

A: The tablets should be stored in a cool, dry place away from direct sunlight and moisture. Adhering to the recommended storage conditions helps maintain the tablets potency and extends their shelf life up to 24 months.

Q: What process is followed for obtaining Erlonat 150 Tablet?

A: Erlonat 150 is a prescription-only medication. You need to consult your doctor and secure a valid prescription. Once prescribed, it can be obtained from licensed pharmacies or authorized suppliers.

Q: How does the route of administration influence the usage of Erlonat 150 Tablet?

A: Erlonat 150 is administered orally, which allows patients to receive anti-cancer therapy conveniently at home, under the guidance and supervision of their healthcare provider.

Tell us about your requirement